Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer-Reference-Cited by-同舟云学术

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

Published:2016-10-01 Issue:10 Volume:2 Page:1303
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Powles Thomas¹,Sarwar Naveed²,Stockdale Andrew³,Sarker Shah-Jalal⁴,Boleti Ekaterini⁵,Protheroe Andrew⁶,Jones Robert⁷,Chowdhury Simon⁸,Peters John⁴,Oades Grenville⁷,O’Brien Tim⁸,Sullivan Mark⁶,Aitchison Michael⁵,Beltran Luis⁴,Worth Daniel⁴,Smith Kate⁴,Michel Constance⁴,Trevisan Giorgia⁴,Harvey-Jones Elizabeth⁴,Wimalasingham Akhila⁴,Sahdev Anju⁴,Ackerman Charlotte⁴,Crabb Simon⁹

Affiliation:

1. Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, England2Department of Medical Oncology, Royal Free NHS Foundation Trust, London, England

2. Department of Oncology, Imperial College, London, England

3. Arden Cancer Centre, University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, England

4. Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, England

5. Department of Medical Oncology, Royal Free NHS Foundation Trust, London, England

6. Department of Medical Oncology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, England

7. Beatson West of Scotland Cancer Centre, Glasgow, Scotland

8. Department of Medical Oncology, Guy’s and St Thomas’ NHS Foundation Trust, London, England

9. Cancer Sciences Unit, University of Southampton, Southampton, England

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression;Cancer Letters;2024-07

2. Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study;Diseases;2024-06-04

3. Perioperative systemic treatments in renal cell carcinoma;Frontiers in Oncology;2024-05-21

4. Role of Surgery in Metastatic Renal Cell Carcinoma;Hematology/Oncology Clinics of North America;2023-10

5. The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma;Cancers;2023-07-29